CPA inhibitor 5mg
-
Catalog numberCS-0335-5mg
-
PricePlease ask
-
Size5mg
-
-
Alternative_Namescarboxypeptidase inhibitor
-
CAS223532-02-3
-
Purity>98%
-
MWt313.35
-
FormulaC18H19NO4
-
Solubility10 mM in DMSO
-
Clinical_InformationNo Development Reported
-
PathwayMetabolic Enzyme/Protease
-
TargetCarboxypeptidase
-
DescriptionTissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
-
Gene target
-
Gene symbolCPA1
-
Short nameCPA inhibitor 5mg
-
Alternative nameCPA suppressor 5mg
-
Gene info
-
Identity
-
Gene
-
Long gene namecarboxypeptidase A1
-
Synonyms gene
-
Synonyms gene name
- carboxypeptidase A1 (pancreatic)
-
Synonyms name
-
Locus
-
Discovery year1986-01-01
-
Entrez gene record
-
RefSeq identity
-
Classification
- M14 carboxypeptidases
-
VEGA ID